<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39439407</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2757-6256</ISSN><JournalIssue CitedMedium="Print"><Volume>59</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>02</Day></PubDate></JournalIssue><Title>Turkish archives of pediatrics</Title><ISOAbbreviation>Turk Arch Pediatr</ISOAbbreviation></Journal><ArticleTitle>Exploring the Therapeutic Potential of Vitamin D in Kawasaki Disease and Its Interplay with the COVID-19.</ArticleTitle><Pagination><StartPage>432</StartPage><EndPage>439</EndPage><MedlinePgn>432-439</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5152/TurkArchPediatr.2024.24141</ELocationID><Abstract><AbstractText>Several studies have reported outbreaks of Kawasaki disease among children amid the coronavirus disease 2019 (COVID-19) pandemic. Vitamin D possesses high utility in modulating the immune system to repair and prevent severe inflammation in COVID-19. This study aims to explore the association between Kawasaki disease and vitamin D levels in pediatric patients and describe the potential role of vitamin D in promoting recovery and preventing complications associated with Kawasaki disease in pediatric patients with COVID-19. The association between Kawasaki disease and vitamin D was explored adhering to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines, utilizing databases such as PubMed, Google Scholar, and ScienceDirect. The association between COVID-19 and Kawasaki disease was also assessed by reviewing relevant literature.Most studies indicated that patients with Kawasaki disease had lower vitamin D levels. Vitamin D supplementation was also found to be deficient in the pediatric population with Kawasaki disease. Inflammation of the endothelium, cytokine storms, and endothelial dysfunction in patients suffering from COVID-19 may contribute to the development of Kawasaki disease. Vitamin D is believed to have protective potential for Kawasaki disease outcomes by modulating the inflammatory response. Administering vitamin D to pediatric patients with viral infections like COVID-19 is expected to accelerate clinical improvement and prevent complications from Kawasaki disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Visuddho</LastName><ForeName>Visuddho</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Medical Program, Universitas Airlangga Faculty of Medicine, Surabaya, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Welliam</LastName><ForeName>Yongki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Medical Program, Universitas Airlangga Faculty of Medicine, Surabaya, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maitri Aldian</LastName><ForeName>Fan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Medical Program, Universitas Airlangga Faculty of Medicine, Surabaya, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tri Arif Sampurna</LastName><ForeName>Mahendra</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Airlangga Teaching Hospital, Universitas Airlangga Faculty of Medicine, Surabaya, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Dr Soetomo General Hospital, Universitas Airlangga Faculty of Medicine, Surabaya, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Irzaldy</LastName><ForeName>Abyan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands, GD.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Turkey</Country><MedlineTA>Turk Arch Pediatr</MedlineTA><NlmUniqueID>101776822</NlmUniqueID><ISSNLinking>2757-6256</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Child health</Keyword><Keyword MajorTopicYN="N">Kawasaki disease</Keyword><Keyword MajorTopicYN="N">vitamin D</Keyword></KeywordList><CoiStatement><b>Declaration of Interests:</b> The authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>3</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39439407</ArticleId><ArticleId IdType="pmc">PMC11391221</ArticleId><ArticleId IdType="doi">10.5152/TurkArchPediatr.2024.24141</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 among children in china. Pediatrics. 2020;145(6). (10.1542/peds.2020-0702)</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2020-0702</ArticleId><ArticleId IdType="pubmed">32179660</ArticleId></ArticleIdList></Reference><Reference><Citation>Visuddho V, Subagjo A, Setyoningrum RA, Rosyid AN. Survival analysis and outcome prediction of COVID-19 patients: a retrospective observational study from tertiary referral hospital in Indonesia. Trop Biomed. 2022;39(2):239 246. (10.47665/tb.39.2.013)</Citation><ArticleIdList><ArticleId IdType="doi">10.47665/tb.39.2.013</ArticleId><ArticleId IdType="pubmed">35838097</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonçalves LF, Gonzales AI, Patatt FSA. Paiva KM, Haas P. Kawasaki and COVID-19 disease in children: a systematic review. Rev Assoc Med Bras (1992), 2020;66 Suppl 2(Suppl 2):136 142.</Citation><ArticleIdList><ArticleId IdType="pubmed">32965372</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395(10239):1771 1778. (10.1016/S0140-6736(20)31103-X)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31103-X</ArticleId><ArticleId IdType="pmc">PMC7220177</ArticleId><ArticleId IdType="pubmed">32410760</ArticleId></ArticleIdList></Reference><Reference><Citation>McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17):e927 e999. (10.1161/CIR.0000000000000484)</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000484</ArticleId><ArticleId IdType="pubmed">28356445</ArticleId></ArticleIdList></Reference><Reference><Citation>Son MBF, Newburger JW. Kawasaki disease. Pediatr Rev. 2018;39(2):78 90. (10.1542/pir.2016-0182)</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/pir.2016-0182</ArticleId><ArticleId IdType="pubmed">29437127</ArticleId></ArticleIdList></Reference><Reference><Citation>Şener S, Batu ED, Kaya Akca Ü, et al. Differentiating multisystem inflammatory syndrome in children from Kawasaki disease during the pandemic. Turk Arch Pediatr. 2024;59(2):150 156. (10.5152/TurkArchPediatr.2024.23192)</Citation><ArticleIdList><ArticleId IdType="doi">10.5152/TurkArchPediatr.2024.23192</ArticleId><ArticleId IdType="pmc">PMC11059258</ArticleId><ArticleId IdType="pubmed">38454223</ArticleId></ArticleIdList></Reference><Reference><Citation>Dietz SM, Tacke CE, de Groot E, et al. Extracardial vasculopathy after Kawasaki disease: a long-term follow-up study. J Am Heart Assoc. 2016;5(7). (10.1161/JAHA.116.003414)</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.116.003414</ArticleId><ArticleId IdType="pmc">PMC5015378</ArticleId><ArticleId IdType="pubmed">27381760</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones VG, Mills M, Suarez D, et al. COVID-19 and Kawasaki disease: novel virus and novel case. Hosp Pediatr. 2020;10(6):537 540. (10.1542/hpeds.2020-0123)</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/hpeds.2020-0123</ArticleId><ArticleId IdType="pubmed">32265235</ArticleId></ArticleIdList></Reference><Reference><Citation>Roh DE, Kwon JE, Kim YH. Diagnosis and management of Kawasaki disease. J Korean Med Assoc. 2020;63(7):374 381. (10.5124/jkma.2020.63.7.374)</Citation><ArticleIdList><ArticleId IdType="doi">10.5124/jkma.2020.63.7.374</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns JC, Hoshino S, Kobayashi T. Kawasaki disease: an essential comparison of coronary artery aneurysm criteria. Lancet Child Adolesc Health. 2018;2(12):840 841. (10.1016/S2352-4642(18)30334-1)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(18)30334-1</ArticleId><ArticleId IdType="pubmed">30337184</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilezikian JP, Bikle D, Hewison M, et al. Mechanisms in endocrinology: vitamin D and COVID-19. Eur J Endocrinol. 2020;183(5):R133 R147. (10.1530/EJE-20-0665)</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-20-0665</ArticleId><ArticleId IdType="pmc">PMC9494342</ArticleId><ArticleId IdType="pubmed">32755992</ArticleId></ArticleIdList></Reference><Reference><Citation>Stagi S, Rigante D, Lepri G, Matucci Cerinic M, Falcini F. Severe vitamin D deficiency in patients with Kawasaki disease: a potential role in the risk to develop heart vascular abnormalities? Clin Rheumatol. 2016;35(7):1865 1872. (10.1007/s10067-015-2970-6)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-015-2970-6</ArticleId><ArticleId IdType="pubmed">25994612</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. (10.1136/bmj.n71)</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M. Cochrane handbook for systematic reviews of interventions. bpsicpr. 2020;15(2):123 125. (10.53841/bpsicpr.2020.15.2.123)</Citation><ArticleIdList><ArticleId IdType="doi">10.53841/bpsicpr.2020.15.2.123</ArticleId></ArticleIdList></Reference><Reference><Citation>Methley AM, Campbell S, Chew-Graham C, McNally R, Cheraghi-Sohi S. PICO, PICOS and Spider: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews. BMC Health Serv Res. 2014;14(1):579. (10.1186/s12913-014-0579-0)</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-014-0579-0</ArticleId><ArticleId IdType="pmc">PMC4310146</ArticleId><ArticleId IdType="pubmed">25413154</ArticleId></ArticleIdList></Reference><Reference><Citation>
Wells G, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed August 11, 2024.</Citation></Reference><Reference><Citation>Meyer K, Volkmann A, Hufnagel M, et al. Breastfeeding and vitamin D supplementation reduce the risk of Kawasaki disease in a German population-based case-control study. BMC Pediatr. 2019;19(1):66. (10.1186/s12887-019-1438-2)</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12887-019-1438-2</ArticleId><ArticleId IdType="pmc">PMC6390341</ArticleId><ArticleId IdType="pubmed">30808315</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Li W. Changes of serum 25-hydroxyvitamin D3 and interleukin-6 after treatment with intravenous immunoglobulins in children with Kawasaki disease. Nan Fang Yi Ke Da Xue Xue Bao. 2014;34(8):1230 1232.</Citation><ArticleIdList><ArticleId IdType="pubmed">25176105</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YD, Li RM, Ji CY, et al. Changes in 25-hydroxyvitamin D3 level and its significance in children with Kawasaki disease. Zhongguo Dang Dai Er Ke Za Zhi. 2016;18(3):211 214. (10.7499/j.issn.1008-8830.2016.03.004)</Citation><ArticleIdList><ArticleId IdType="doi">10.7499/j.issn.1008-8830.2016.03.004</ArticleId><ArticleId IdType="pmc">PMC7390001</ArticleId><ArticleId IdType="pubmed">26975816</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YL, Wang JL, Li WQ. Prediction of the risk of coronary arterial lesions in Kawasaki disease by serum 25-hydroxyvitamin D3. Eur J Pediatr. 2014;173(11):1467 1471. (10.1007/s00431-014-2346-y)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-014-2346-y</ArticleId><ArticleId IdType="pmc">PMC4194745</ArticleId><ArticleId IdType="pubmed">24889335</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi XL, Chen LL, Sun XG, Li XM, Zhao LH, Kong DJ. 1,25-dihydroxyvitamin D3 regulates T lymphocyte proliferation through activation of P53 and inhibition of ERK1/2 signaling pathway in children with Kawasaki disease. Eur Rev Med Pharmacol Sci. 2017;21(16):3714 3722.</Citation><ArticleIdList><ArticleId IdType="pubmed">28925469</ArticleId></ArticleIdList></Reference><Reference><Citation>An X, Fu M, Tian J, Xue Y, Xu H. Significance of serum 25-hydroxyvitamin D3 and interleukin-6 levels in immunoglobulin treatment of Kawasaki disease in children. Exp Ther Med. 2016;12(3):1476 1480. (10.3892/etm.2016.3492)</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2016.3492</ArticleId><ArticleId IdType="pmc">PMC4998228</ArticleId><ArticleId IdType="pubmed">27602072</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki Y, Ichiyama T, Ohsaki A, Hasegawa S, Shiraishi M, Furukawa S. Anti-inflammatory effect of 1alpha,25-dihydroxyvitamin D(3) in human coronary arterial endothelial cells: implication for the treatment of Kawasaki disease. J Steroid Biochem Mol Biol. 2009;113(1-2):134 138. (10.1016/j.jsbmb.2008.12.004)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsbmb.2008.12.004</ArticleId><ArticleId IdType="pubmed">19138739</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichiyama T, Yoshitomi T, Nishikawa M, et al. NF-kappaB activation in peripheral blood monocytes/macrophages and T cells during acute Kawasaki disease. Clin Immunol. 2001;99(3):373 377. (10.1006/clim.2001.5026)</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/clim.2001.5026</ArticleId><ArticleId IdType="pubmed">11358434</ArticleId></ArticleIdList></Reference><Reference><Citation>Berthelot JM, Drouet L, Lioté F. Kawasaki-like diseases and thrombotic coagulopathy in COVID-19: delayed over-activation of the STING pathway? Emerg Microbes Infect. 2020;9(1):1514 1522. (10.1080/22221751.2020.1785336)</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1785336</ArticleId><ArticleId IdType="pmc">PMC7473058</ArticleId><ArticleId IdType="pubmed">32574107</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo W, Wang Y, Zhang L, et al. Critical role of cytosolic DNA and its sensing adaptor STING in aortic degeneration, dissection, and rupture. Circulation. 2020;141(1):42 66. (10.1161/CIRCULATIONAHA.119.041460)</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.119.041460</ArticleId><ArticleId IdType="pmc">PMC6939474</ArticleId><ArticleId IdType="pubmed">31887080</ArticleId></ArticleIdList></Reference><Reference><Citation>Coll-Bonfill N, Cancado de Faria R, Bhoopatiraju S, Gonzalo S. Calcitriol prevents RAD51 loss and cGAS-STING-IFN response triggered by Progerin. Proteomics. 2020;20(5-6):e1800406. (10.1002/pmic.201800406)</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.201800406</ArticleId><ArticleId IdType="pmc">PMC7117971</ArticleId><ArticleId IdType="pubmed">31834988</ArticleId></ArticleIdList></Reference><Reference><Citation>Jun JS, Jung YK, Lee DW. Relationship between vitamin D levels and intravenous immunoglobulin resistance in Kawasaki disease. Korean J Pediatr. 2017;60(7):216 220. (10.3345/kjp.2017.60.7.216)</Citation><ArticleIdList><ArticleId IdType="doi">10.3345/kjp.2017.60.7.216</ArticleId><ArticleId IdType="pmc">PMC5573744</ArticleId><ArticleId IdType="pubmed">28861112</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L, Tang K, Levin M, et al. COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect Dis. 2020;20(11):e276 e288. (10.1016/S1473-3099(20)30651-4)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30651-4</ArticleId><ArticleId IdType="pmc">PMC7431129</ArticleId><ArticleId IdType="pubmed">32818434</ArticleId></ArticleIdList></Reference><Reference><Citation>Haslak F, Gunalp A, Kasapcopur O. A cursed goodbye kiss from severe acute respiratory syndrome-coronavirus-2 to its pediatric hosts: multisystem inflammatory syndrome in children. Curr Opin Rheumatol. 2023;35(1):6 16. (10.1097/BOR.0000000000000910)</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000910</ArticleId><ArticleId IdType="pubmed">36094472</ArticleId></ArticleIdList></Reference><Reference><Citation>Toubiana J, Poirault C, Corsia A, et al. Kawasaki-like multisystem inflammatory syndrome in children during the Covid-19 pandemic in Paris, France: prospective observational study. BMJ. 2020;369:m2094. (10.1136/bmj.m2094)</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m2094</ArticleId><ArticleId IdType="pmc">PMC7500538</ArticleId><ArticleId IdType="pubmed">32493739</ArticleId></ArticleIdList></Reference><Reference><Citation>Libby P, Lüscher T. COVID-19 is, in the end, an endothelial disease. Eur Heart J. 2020;41(32):3038 3044. (10.1093/eurheartj/ehaa623)</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa623</ArticleId><ArticleId IdType="pmc">PMC7470753</ArticleId><ArticleId IdType="pubmed">32882706</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S, Chen M, Weng J. COVID-19 and Kawasaki disease in children. Pharmacol Res. 2020;159:104951. (10.1016/j.phrs.2020.104951)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2020.104951</ArticleId><ArticleId IdType="pmc">PMC7247462</ArticleId><ArticleId IdType="pubmed">32464327</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahdah N. A tale of a trail on how it takes 5 days of Kawasaki disease to initiate coronary artery injury and change the lives of children. Turk Arch Pediatr. 2024;59(2):131 134. (10.5152/TurkArchPediatr.2024.23254)</Citation><ArticleIdList><ArticleId IdType="doi">10.5152/TurkArchPediatr.2024.23254</ArticleId><ArticleId IdType="pmc">PMC11059558</ArticleId><ArticleId IdType="pubmed">38454220</ArticleId></ArticleIdList></Reference><Reference><Citation>Consiglio CR, Cotugno N, Sardh F, et al. The immunology of multisystem inflammatory syndrome in children with COVID-19. Cell. 2020;183(4):968 981.e7. (10.1016/j.cell.2020.09.016)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7474869</ArticleId><ArticleId IdType="pubmed">32966765</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruber CN, Patel RS, Trachtman R, et al. Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C). Cell. 2020;183(4):982 995.e14. (10.1016/j.cell.2020.09.034)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.034</ArticleId><ArticleId IdType="pmc">PMC7489877</ArticleId><ArticleId IdType="pubmed">32991843</ArticleId></ArticleIdList></Reference><Reference><Citation>Richetta C, Faure M. Autophagy in antiviral innate immunity. Cell Microbiol. 2013;15(3):368 376. (10.1111/cmi.12043)</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cmi.12043</ArticleId><ArticleId IdType="pubmed">23051682</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuk JM, Shin DM, Lee HM, et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe. 2009;6(3):231 243. (10.1016/j.chom.2009.08.004).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2009.08.004</ArticleId><ArticleId IdType="pubmed">19748465</ArticleId></ArticleIdList></Reference><Reference><Citation>Teymoori-Rad M, Shokri F, Salimi V, Marashi SM. The interplay between vitamin D and viral infections. Rev Med Virol. 2019;29(2):e2032. (10.1002/rmv.2032)</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2032</ArticleId><ArticleId IdType="pubmed">30614127</ArticleId></ArticleIdList></Reference><Reference><Citation>Borsche L, Glauner B, von Mendel J. COVID-19 mortality risk correlates inversely with vitamin D3 status, and a mortality rate close to zero could theoretically be achieved at 50 ng/mL 25(OH)D3: results of a systematic review and meta-analysis. Nutrients. 2021;13(10). (10.3390/nu13103596)</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13103596</ArticleId><ArticleId IdType="pmc">PMC8541492</ArticleId><ArticleId IdType="pubmed">34684596</ArticleId></ArticleIdList></Reference><Reference><Citation>Honardoost M, Ghavideldarestani M, Khamseh ME. Role of vitamin D in pathogenesis and severity of COVID-19 infection. Arch Physiol Biochem. 2023;129(1):26 32. (10.1080/13813455.2020.1792505)</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13813455.2020.1792505</ArticleId><ArticleId IdType="pubmed">33125298</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni W, Yang X, Yang D, et al. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit Care. 2020;24(1):422. (10.1186/s13054-020-03120-0)</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03120-0</ArticleId><ArticleId IdType="pmc">PMC7356137</ArticleId><ArticleId IdType="pubmed">32660650</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos RAS, Sampaio WO, Alzamora AC, et al. The ACE2/angiotensin-(1-7)/MAS axis of the renin-angiotensin system: focus on angiotensin-(1-7). Physiol Rev. 2018;98(1):505 553. (10.1152/physrev.00023.2016)</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00023.2016</ArticleId><ArticleId IdType="pmc">PMC7203574</ArticleId><ArticleId IdType="pubmed">29351514</ArticleId></ArticleIdList></Reference><Reference><Citation>Entrenas Castillo M, Entrenas Costa LM, Vaquero Barrios JM, et al. Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: a pilot randomized clinical study. J Steroid Biochem Mol Biol. 2020;203:105751. (10.1016/j.jsbmb.2020.105751)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsbmb.2020.105751</ArticleId><ArticleId IdType="pmc">PMC7456194</ArticleId><ArticleId IdType="pubmed">32871238</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufman HW, Niles JK, Kroll MH, Bi C, Holick MF. SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels. PLoS One. 2020;15(9):e0239252. (10.1371/journal.pone.0239252)</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0239252</ArticleId><ArticleId IdType="pmc">PMC7498100</ArticleId><ArticleId IdType="pubmed">32941512</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzini A, Aichner M, Sahanic S, et al. Impact of vitamin D deficiency on COVID-19-A prospective analysis from the CovILD registry. Nutrients. 2020;12(9). (10.3390/nu12092775)</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12092775</ArticleId><ArticleId IdType="pmc">PMC7551662</ArticleId><ArticleId IdType="pubmed">32932831</ArticleId></ArticleIdList></Reference><Reference><Citation>Padhi S, Suvankar S, Panda VK, Pati A, Panda AK. Lower levels of vitamin D are associated with SARS-CoV-2 infection and mortality in the Indian population: an observational study. Int Immunopharmacol. 2020;88:107001. (10.1016/j.intimp.2020.107001)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2020.107001</ArticleId><ArticleId IdType="pmc">PMC7489890</ArticleId><ArticleId IdType="pubmed">33182040</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>